Dan Ferry
Investor Relations
Replay available
Praxis Precision Medicines, Inc. (PRAX) Q4 2025 Earnings Call
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) Q4 2025 earnings conference call, held 2026-02-19. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Marcio Souza
President and Chief Executive Officer
Tim Kelly
Chief Financial Officer
Yasmine Rahimi
Piper Sandler Analyst
Athena Chin
TD Cowen Analyst
Guggenheim Analyst
Analyst
Jun Li
Truist Securities Analyst
Andrew Say
Jefferies Analyst
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Praxis Precision Medicines, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.237 and thank you for standing by. Welcome to the Praxis Precision Medicine's fourth 00:00:05.237 -- 00:00:10.343 quarter and full year 2025 earnings call. At this time, all participants are in a listen-only 00:00:10.343 -- 00:00:14.087 mode. After the speaker's presentation, there will be a question and answer session. 00:00:14.087 -- 00:00:18.853 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:18.853 -- 00:00:22.077 You will then hear an automated message advising your hand is raised. 00:00:22.077 -- 00:00:25.200 To withdraw your question, please press star 11 again. 00:00:25.200 -- 00:00:28.010 Please be advised that today's conference is being recorded. 00:00:28.010 -- 00:00:31.234 I would now like to hand the conference over to your speaker today, Dan Ferry, Investor 00:00:31.234 -- 00:00:34.336 Relations. Please go ahead. 00:00:34.539 -- 00:00:38.323 Good morning, and welcome to the Praxis Precision Medicine's fourth quarter and full 00:00:38.323 -- 00:00:42.689 year 2025 Financial Results and Business Update conference call. 00:00:42.689 -- 00:00:46.194 This call is being webcast live and can be accessed on the Investor section of Praxis' 00:00:46.194 -- 00:00:49.515 website at www.praxismedicines.com. 00:00:51.100 -- 00:00:54.144 Please note that remarks made during this call may contain forward-looking statements 00:00:54.144 -- 00:00:58.968 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:00:59.212 -- 00:01:03.257 These may include statements about the company's future expectations and plans, clinical 00:01:03.257 -- 00:01:07.021 development timelines, and financial projections. 00:01:07.021 -- 00:01:10.806 While these forward-looking statements repre...